A Look At Pro Medicus (ASX:PME) Valuation After Half Year Earnings And Interim Dividend Announcement

Simply Wall St.

Feb 25

AdvertisementHalf year results and dividend announcement Pro Medicus (ASX:PME) has drawn investor attention after releasing half year results alongside an interim dividend on ordinary fully paid ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2614709834"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2614709834\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2614709834?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","is_english":true,"pubTime":"2026-02-25 15:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2614709834","market":"nz","top_or_hot":-1,"title":"A Look At Pro Medicus (ASX:PME) Valuation After Half Year Earnings And Interim Dividend Announcement","media":"Simply Wall St.","content":"<div>\n<p>AdvertisementHalf year results and dividend announcement Pro Medicus (ASX:PME) has drawn investor attention after releasing half year results alongside an interim dividend on ordinary fully paid ...</p>\n\n<a href=\"https://simplywall.st/stocks/au/healthcare/asx-pme/pro-medicus-shares/news/a-look-at-pro-medicus-asxpme-valuation-after-half-year-earni\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Look At Pro Medicus (ASX:PME) Valuation After Half Year Earnings And Interim Dividend Announcement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Look At Pro Medicus (ASX:PME) Valuation After Half Year Earnings And Interim Dividend Announcement\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-25 15:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/au/healthcare/asx-pme/pro-medicus-shares/news/a-look-at-pro-medicus-asxpme-valuation-after-half-year-earni><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AdvertisementHalf year results and dividend announcement Pro Medicus (ASX:PME) has drawn investor attention after releasing half year results alongside an interim dividend on ordinary fully paid ...</p>\n\n<a href=\"https://simplywall.st/stocks/au/healthcare/asx-pme/pro-medicus-shares/news/a-look-at-pro-medicus-asxpme-valuation-after-half-year-earni\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PME","symbol_name":"平潭海洋实业有限公司","start_time":0,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-pme/pro-medicus-shares/news/a-look-at-pro-medicus-asxpme-valuation-after-half-year-earni","article_id":"2614709834","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-pme/pro-medicus-shares/news/a-look-at-pro-medicus-asxpme-valuation-after-half-year-earni","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2614709834","pubTimestamp":1772004494,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Half year results and dividend announcement\nPro Medicus (ASX:PME) has drawn investor attention after releasing half year results alongside an interim dividend on ordinary fully paid shares, combining earnings detail with a specific cash distribution timeline.\nSee our latest analysis for Pro Medicus.\nThe interim dividend and strong half year earnings update arrive after a challenging period for shareholders, with a 30 day share price return of 35.76% decline and a 1 year total shareholder...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"PME":"平潭海洋实业有限公司","PME.AU":"PRO MEDICUS LTD"},"translate_title":"半年收益和中期股息公告后Pro Medicus(ASX：PME)估值一览","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PME.AU":1.5,"PME":1.5},"content_text":"AdvertisementHalf year results and dividend announcement Pro Medicus (ASX:PME) has drawn investor attention after releasing half year results alongside an interim dividend on ordinary fully paid shares, combining earnings detail with a specific cash distribution timeline. See our latest analysis for Pro Medicus. The interim dividend and strong half year earnings update arrive after a challenging period for shareholders, with a 30 day share price return of 35.76% decline and a 1 year total shareholder return of 57.37% decline. However, the 3 year and 5 year total shareholder returns of 92.70% and 156.25% indicate that long term holders have still seen meaningful gains. If this latest move in Pro Medicus has you reassessing healthcare and tech exposure, it could be a good moment to review 10 healthcare AI stocks for potential next ideas to research. With the share price under pressure despite strong recent earnings and an interim dividend on the way, you have to ask: is Pro Medicus now trading below its true worth, or is the market already baking in years of future growth? Most Popular Narrative: 13.1% Undervalued Pro Medicus last closed at A$116.23, while the most followed narrative, according to Robbo, sets fair value at A$133.68 using a specific cash flow and margin profile.  Pro Medicus also boasts an exceptional balance sheet, with very high cash reserves and negligible debt. Its directors retain a substantial ownership stake, signalling strong confidence in the business. The company’s growth has been consistently impressive, with Return on Assets (ROA) at 40% and Return on Equity (ROE) at 42%. The current ratio stands at 5.97, reflecting strong liquidity.  Read the complete narrative. Want to see what kind of revenue path and profit margins sit behind that valuation gap? The narrative leans on punchy profitability and a future earnings multiple that expects those strengths to hold. Curious how those ingredients combine to get to A$133.68 rather than today’s share price? The full story connects those assumptions line by line. Result: Fair Value of A$133.68 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, that story can change quickly if high P/E expectations reset or a key hospital customer shifts spend toward larger competitors that offer rival imaging platforms. Find out about the key risks to this Pro Medicus narrative. Another Take on Value: P/E Ratios Paint a Richer Picture Robbo’s narrative points to a 13.1% undervaluation at A$133.68, but the current P/E of 48.1x tells a different story. It sits above the fair ratio of 33.8x, above the peer average of 40.8x, and above the global Healthcare Services average of 30.1x, which suggests valuation risk if sentiment cools. If you prefer to keep things grounded in simple earnings multiples, See what the numbers say about this price — find out in our valuation breakdown. can help you see how this rich P/E stack up against other candidates you might be researching. ASX:PME P/E Ratio as at Feb 2026Next Steps If this mix of risks and rewards feels finely balanced, take a moment to scan the numbers yourself and form your own view before the next headlines hit. To weigh up both sides in one place, have a look at 2 key rewards and 1 important warning sign. Ready for more investment ideas? If Pro Medicus has sharpened your thinking, do not stop here. Use the Simply Wall St screener to spot other opportunities before they move without you.  Target quality at a discount by reviewing companies in 7 high quality undervalued stocks that pair robust fundamentals with share prices that may sit below their implied worth. Explore potential income streams by scanning 9 dividend fortresses for businesses offering higher yields that still aim to keep payouts supported by their cash flows. Focus on resilience first by working through the 6 resilient stocks with low risk scores to see which companies score well on stability and financial strength.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}